- 询价
- MedChemExpress(MCE)
- 美国
- HY-111378A
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- CAS号：
2320347-54-2
- 规格：
询盘
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Casein Kinase II Inhibitor IV hydrochloride
CAS No. : 2320347-54-2
MCE 国际站：Casein Kinase II Inhibitor IV hydrochloride
产品活性：Casein Kinase II Inhibitor IV Hydrochloride 是表皮角质形成细胞分化的小分子诱导剂。
研究领域：Cell Cycle/DNA Damage | Stem Cell/Wnt
作用靶点：Casein Kinase
In Vitro: Treatment of human epidermal keratinocytes (NHEKs) with Casein Kinase II Inhibitor IV leads to an increase in the early differentiation markers keratins 1 and 10 at 48 h. Increased levels of IVL and TGM are observed in cells treated with Casein Kinase II Inhibitor IV at 72 h and persisted at 96 h. In addition, treated with Casein Kinase II Inhibitor IV expresses loricrin, a terminal differentiation marker, at later time points. Similar results are observed by messenger RNA (mRNA) expression analysis of NHEKs treated with Casein Kinase II Inhibitor IV. At early time points (12 and 24 h), treatment with Casein Kinase II Inhibitor IV leads to the upregulation of keratinocyte early differentiation marker genes, including keratin 1 (5.4-fold) and keratin 10 (5.4-fold). Terminal differentiation marker genes, including IVL (1.8-fold), TGM 1 (4.8-fold), loricrin (3.3-fold), and filaggrin (5.6-fold), are upregulated at late time points (36 and 48 h). These results are consistent with the ability of Casein Kinase II Inhibitor IV to induce differentiation of epidermal progenitor cells into terminally differentiated keratinocytes.
相关产品：LY294002 | Silmitasertib | IWP-2 | Emodin | Ellagic acid | D4476 | Umbralisib | PF-670462 dihydrochloride | TBB | TMX-4116 | Casein Kinase inhibitor A51 | DMAT | PF-4800567 | (E/Z)-GO289 | SR-3029 | SSTC3 | IC261 | TAK-715 | FPFT-2216 | CKI-7 free base | SGC-CK2-1 | CK1-IN-1 | TTP 22 | BTX161 | AMG-548 dihydrochloride | BioE-1115 | Hematein | TA-01 | MRT00033659
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification of Myosin Light Chain Kinase
inhibitor* - 8ml of 1mg/ml stock solution pH 7.0 3.Buffer B DE 52 Wash 10 mM MOPS- 20ml of 2M stock solution 4 liters 1 mM EDTA- 20ml of 0.2M stock solution 1 mM DTT* - 4ml of 1M stock solution 0.1 mM PMSF* - 7ml of 10mg/ml stock solution pH
Using Phospho‐Motif Antibodies to Determine Kinase Substrates
., Graves, D.J., DeMaggio, A.J., Hoekstra, M.F., Blenis, J., Hunter, T., and Cantley, L.C. 1996. A structural basis for substrate specificities of protein Ser/Thr kinases: Primary sequence preference of. casein kinases I and II, NIMA, phosphorylase kinase
V294.PART II，Chapter 2 Boyden法体外趋化试验
PART II：BASIC CELL MIGRATION AND RELATED ASSAYS vol.294 Guan J.-L. (ed.) Cell Migration-Developmental Methods and Protocols Chapter 2 Boyden Chamber Assay Summary The Boyden chamber assay, originally introduced by Boyden
技术资料暂无技术资料 索取技术资料
